Systems pharmacology analysis of oncology drug combinations to evaluate adverse events due to drug-drug interactions

被引:0
|
作者
Kim, Sarah [1 ]
Lahu, Gezim [2 ]
Lesko, Lawrence J. [1 ]
Trame, Mirjam N. [1 ]
机构
[1] Univ Florida, Ctr Pharmacometr & Syst Pharmacol, Orlando, FL USA
[2] Takeda Pharmaceut Int GmbH, Zurich, Switzerland
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
W-68
引用
收藏
页码:S115 / S116
页数:2
相关论文
共 50 条
  • [31] Systems analysis of adverse drug events
    Huff, ED
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (01): : 33 - 34
  • [32] Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review
    Boudou-Rouquette, Pascaline
    Tlemsani, Camille
    Blanchet, Benoit
    Huillard, Olivier
    Jouinot, Anne
    Arrondeau, Jennifer
    Thomas-Schoemann, Audrey
    Vidal, Michel
    Alexandre, Jerome
    Goldwasser, Francois
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (12) : 1433 - 1444
  • [33] Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer
    Fogli, Stefano
    Gianfilippo, Giulia
    Cucchiara, Federico
    Re, Marzia Del
    Valerio, Laura
    Elisei, Rossella
    Danesi, Romano
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 163
  • [34] Systems Pharmacology based approach utilized for prediction of the cardiac consequences of drug-drug interactions
    Wisniowska, Barbara
    Badyra, Bogna
    Lisowski, Bartosz
    Polak, Sebastian
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 353 - 353
  • [35] An in vitro test system to evaluate drug-drug interactions with biologics
    Czerwinski, Maciej
    Renneke, Christina
    Parker, Joanne
    Pope, Chad
    Lyon, Kevin
    Wiegand, Catherine
    Neat, Jason
    Kazmi, Faraz
    Buckley, David
    Parkinson, Andrew
    DRUG METABOLISM REVIEWS, 2011, 43 : 91 - 92
  • [36] Surveillance of adverse drug reactions and drug-drug interactions with pediatric oncology patients in a south Indian tertiary care hospital
    Joseph, Bency
    Scott, Julius X.
    Ganesan, Rajanandh M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (05) : 1103 - 1109
  • [37] DRUG-DRUG INTERACTIONS
    FORTH, W
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1976, 26 (NA1): : 108 - 114
  • [38] Drug-drug interactions
    Preskorn, SH
    JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 (05) : 223 - 225
  • [39] The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology
    Harmsen, S.
    Meijerman, I.
    Beijnen, J. H.
    Schellens, J. H. M.
    CANCER TREATMENT REVIEWS, 2007, 33 (04) : 369 - 380
  • [40] Drug-drug interactions in oncology: Why are they important and can they be minimized?
    Blower, P
    de Wit, R
    Goodin, S
    Aapro, M
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 55 (02) : 117 - 142